LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Canertinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2953 | 3769 | 0.7835 | 0.6946 |
| BT-20 | Celastrol | 1.11 | uM | LJP6 | 72 | hr | 1097 | 819 | 3769 | 0.2174 | -0.1039 |
| BT-20 | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 627 | 3769 | 0.1664 | -0.1759 |
| BT-20 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 538 | 3769 | 0.1427 | -0.2093 |
| BT-20 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3370 | 3769 | 0.8942 | 0.8507 |
| BT-20 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3148 | 3769 | 0.8353 | 0.7677 |
| BT-20 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3862 | 3769 | 1.0247 | 1.0348 |
| BT-20 | Crizotinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2992 | 3769 | 0.7938 | 0.7092 |
| BT-20 | Momelotinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3047 | 3769 | 0.8083 | 0.7296 |
| BT-20 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 1399 | 3769 | 0.3713 | 0.1132 |
| BT-20 | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 1052 | 3769 | 0.2793 | -0.0167 |
| BT-20 | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 1582 | 3769 | 0.4198 | 0.1815 |
| BT-20 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3931 | 3769 | 1.0428 | 1.0604 |
| BT-20 | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3165 | 3769 | 0.8398 | 0.7740 |
| BT-20 | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 1269 | 3769 | 0.3368 | 0.0645 |
| BT-20 | R406 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3417 | 3769 | 0.9065 | 0.8681 |
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 1267 | 3769 | 0.3361 | 0.0635 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3142 | 3769 | 0.8336 | 0.7653 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 1097 | 1019 | 3769 | 0.2705 | -0.0290 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 1097 | 963 | 3769 | 0.2555 | -0.0502 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 596 | 3769 | 0.1583 | -0.1873 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 775 | 3769 | 0.2058 | -0.1203 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3323 | 3769 | 0.8817 | 0.8332 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 512 | 3769 | 0.1360 | -0.2188 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 1964 | 3769 | 0.5210 | 0.3244 |